Last reviewed · How we verify

NCT05498415: SMS

Feasibility, Acceptability, and Efficacy of the Sleep Move Stand Study

Completed NA Last updated 12 May 2023
What this trial tests

NA trial testing Education in Physical Inactivity in 62 participants. Completed in 27 March 2023.

Timeline
1 September 2022
Primary endpoint
27 March 2023
27 March 2023

Quick facts

Lead sponsorUniversity of Iowa
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment62
Start date1 September 2022
Primary completion27 March 2023
Estimated completion27 March 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Iowa

Who can join

Adults 18 to 80, any sex, with Physical Inactivity or Sedentary Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overarching goal for this project is to develop a service-learning program that provides students excellent hands on training and patients with an excellent service that advances their health and well-being. The aim of this study is to test the feasibility, acceptability and efficacy of an 8 week intervention on physical behaviors, cognitive function, and health outcomes compared to a control condition among sedentary, overweight and obese adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Education

Trials testing the same drug.

Other recruiting trials for Physical Inactivity

Currently open trials in the same condition.

Other University of Iowa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05498415.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing